Announcements Trials
Browse Landscape

Phase

Phase 2 231Phase 1 112Phase 1/2 48Phase 3 47Phase 4 9Phase NA 6Phase EARLY_PHASE1 2Phase 2/3 1

Status

Unknown 6Completed 6Terminated 3Active not recruiting 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Oligometastatic Lung Adenocarcinoma 1Neoplasms 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Completed × Erlotinib Hydrochloride × Clear all
NCT00883480 2026-04-28

SLAT

Spanish Lung Cancer Group

Phase NA Completed
153 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01636908 2021-04-15

ICK

Amsterdam UMC, location VUmc

Phase NA Completed
43 enrolled
Tumor-Agnostic

Neoplasms

NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
12 enrolled 10 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02450591 2018-05-21

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Memorial Sloan Kettering Cancer Center

Phase NA Completed
4 enrolled 7 charts

Oligometastatic Lung Adenocarcinoma

NCT00144976 2015-03-27

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Institut Claudius Regaud

Phase NA Completed
43 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00085280 2014-03-31

Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Completed
129 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡